TriSalus Life Sciences, Inc. (TLSI)
(Delayed Data from NSDQ)
$4.18 USD
-0.05 (-1.18%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $4.20 +0.02 (0.48%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, TriSalus Life Sciences, Inc. has a market cap of $160.06M, which represents its share price of $4.23 multiplied by its outstanding shares number of 37.84M. As a small-cap company, TLSI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TLSI 4.18 -0.05(-1.18%)
Will TLSI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TLSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TLSI
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
TLSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
TerrAscend Corp. (TSNDF) Reports Q1 Loss, Lags Revenue Estimates
SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates
Other News for TLSI
TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference | ...
TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call | TLSI ...
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent ...
TriSalus Life Sciences management to meet virtually with Lake Street
Lake Street Keeps Their Buy Rating on TriSalus Life Sciences (TLSI)